Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Public health impact of androgens
Gen Kanayama, Marc J. Kaufman, Harrison G. Pope
Current Opinion in Endocrinology Diabetes and Obesity (2018) Vol. 25, Iss. 3, pp. 218-223
Open Access | Times Cited: 56

Showing 1-25 of 56 citing articles:

Adverse Effects of Anabolic-Androgenic Steroids: A Literature Review
Giuseppe Albano, Francesco Amico, Giuseppe Cocimano, et al.
Healthcare (2021) Vol. 9, Iss. 1, pp. 97-97
Open Access | Times Cited: 132
Androgen Misuse and Abuse
David J. Handelsman
Endocrine Reviews (2021) Vol. 42, Iss. 4, pp. 457-501
Open Access | Times Cited: 64
Stanozolol-induced liver injury: A distinctive cholestatic clinical and biochemical phenotype at presentation
Vinícius Nunes, María Isabel Schinoni, Fernando Bessone, et al.
Journal of Clinical and Experimental Hepatology (2025) Vol. 15, Iss. 3, pp. 102506-102506
Closed Access | Times Cited: 1
Gendered perspectives on women’s anabolic–androgenic steroid (AAS) usage practices
Timothy Piatkowski, Jonathan Robertson, Séverine Lamon, et al.
Harm Reduction Journal (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 21
Big business: The private sector market for image and performance enhancing drug harm reduction in the UK
Luke A. Turnock, Nick Gibbs, Luke Cox, et al.
International Journal of Drug Policy (2023) Vol. 122, pp. 104254-104254
Open Access | Times Cited: 18
Treatments for people who use anabolic androgenic steroids: a scoping review
Geoff Bates, Marie Claire Van Hout, Joseph Tay Wee Teck, et al.
Harm Reduction Journal (2019) Vol. 16, Iss. 1
Open Access | Times Cited: 43
Effects of Exogenous Androgens on Platelet Activity and Their Thrombogenic Potential in Supraphysiological Administration: A Literature Review
Adrian Roșca, Ana‐Maria Vlădăreanu, Alina Mititelu, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 1, pp. 147-147
Open Access | Times Cited: 30
Aescin Protects against Experimental Benign Prostatic Hyperplasia and Preserves Prostate Histomorphology in Rats via Suppression of Inflammatory Cytokines and COX-2
Mohamed Raafat, Amr Kamel, Alaa H. Shehata, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 2, pp. 130-130
Open Access | Times Cited: 21
Exploring the Impacts of Rurality on Service Access and Harm Among Image and Performance Enhancing Drug (IPED) Users in a Remote English Region
Luke A. Turnock, Kyle Mulrooney
Contemporary Drug Problems (2023) Vol. 50, Iss. 2, pp. 232-253
Open Access | Times Cited: 11
NEUROLOGICAL CONSEQUENCES OF ABUSIVE USE OF ANABOLIC-ANDROGENIC STEROIDS
Lindisley Ferreira Gomides, Leandro Almeida Oliveira, Nicholas Mayers, et al.
Tempus Actas de Saúde Coletiva (2024) Vol. 13, Iss. 1, pp. 102-122
Open Access | Times Cited: 4
Anabolic-Androgenic Steroid Abuse Causes Cardiac Dysfunction
Rabiu Momoh
American Journal of Men s Health (2024) Vol. 18, Iss. 2
Open Access | Times Cited: 4
Use, Misuse and Abuse of Testosterone and Other Androgens
Bruno Lima Linhares, Eduardo Miranda, A. R. S. Cintra, et al.
Sexual Medicine Reviews (2021) Vol. 10, Iss. 4, pp. 583-595
Open Access | Times Cited: 22
Structurally different anabolic androgenic steroids reduce neurite outgrowth and neuronal viability in primary rat cortical cell cultures
Sofia Zelleroth, Erik Nylander, Axel Örtenblad, et al.
The Journal of Steroid Biochemistry and Molecular Biology (2021) Vol. 210, pp. 105863-105863
Open Access | Times Cited: 21
Stigma and the Use of Anabolic Androgenic Steroids by Men in the United Kingdom
Jim McVeigh, Geoff Bates
Springer eBooks (2022), pp. 121-146
Closed Access | Times Cited: 14
The Impact of the COVID-19 Pandemic on Male Strength Athletes Who Use Non-prescribed Anabolic-Androgenic Steroids
Barnaby N. Zoob Carter, Ian D. Boardley, Katinka van de Ven
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 17
Generating evidence on the use of Image and performance enhancing drugs in the UK: results from a scoping review and expert consultation by the Anabolic Steroid UK network
Jim McVeigh, Evelyn Hearne, Ian D. Boardley, et al.
Harm Reduction Journal (2021) Vol. 18, Iss. 1
Open Access | Times Cited: 16
In-Sewer Stability Assessment of Anabolic Steroids and Selective Androgen Receptor Modulators
Katja M. Shimko, Jake O’Brien, Jiaying Li, et al.
Environmental Science & Technology (2022) Vol. 56, Iss. 3, pp. 1627-1638
Open Access | Times Cited: 12
Reliability of Drug History to Verify Androgen Abuse in Men
Nandini Shankara‐Narayana, Lance Brooker, Catrin Goebel, et al.
The Journal of Clinical Endocrinology & Metabolism (2022) Vol. 107, Iss. 9, pp. e3790-e3796
Open Access | Times Cited: 11
ADHD symptoms and use of anabolic androgenic steroids among male weightlifters
Emilie Smith-Meyer Kildal, Bjørnar Hassel, Astrid Bjørnebekk
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 11
A rapid synthesis of molecularly imprinted polymer nanoparticles for the extraction of performance enhancing drugs (PIEDs)
Mark V. Sullivan, Connor Fletcher, Rachel Armitage, et al.
Nanoscale Advances (2023) Vol. 5, Iss. 19, pp. 5352-5360
Open Access | Times Cited: 6
Men´s experiences of using anabolic androgenic steroids
Annica Börjesson, Margaretha Ekebergh, Marja­‐Liisa Dahl, et al.
International Journal of Qualitative Studies on Health and Well-Being (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 14
When Bodybuilding Goes Wrong—Bilateral Renal Artery Thrombosis in a Long-Term Misuser of Anabolic Steroids Treated with AngioJet Rheolytic Thrombectomy
Artur Lemiński, Markiian Kubis, Krystian Kaczmarek, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 4, pp. 2122-2122
Open Access | Times Cited: 9
Do you get what you see? The illicit doping market in Denmark—An analysis of performance and image enhancing drugs seized by the police over a 1‐year period
Pia Johansson Heinsvig, Ask Vest Christiansen, Daniel Ayoubi, et al.
Drug Testing and Analysis (2023) Vol. 15, Iss. 6, pp. 668-677
Open Access | Times Cited: 5
Persistently Decreased Quality of Life and its Determinants in Previous Illicit Androgen Users
Yeliz Bulut, Niels Brandt, Laust Frisenberg Buhl, et al.
The Journal of Clinical Endocrinology & Metabolism (2023) Vol. 109, Iss. 2, pp. e689-e697
Closed Access | Times Cited: 5
Emergence and occurrence of performance-enhancing substance use in Australia determined by wastewater analysis
Katja M. Shimko, Jake O’Brien, Benjamin J. Tscharke, et al.
Nature Water (2023) Vol. 1, Iss. 10, pp. 879-886
Closed Access | Times Cited: 5
Page 1 - Next Page

Scroll to top